| Names | |
|---|---|
| Preferred IUPAC name | (2S)-2-[[4-[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
| Other names | Vitamin B9 Folacin Pteroylglutamic acid Folate |
| Pronunciation | /ˈfəʊ.lɪk ˈæs.ɪd/ |
| Identifiers | |
| CAS Number | 59-30-3 |
| Beilstein Reference | 1723893 |
| ChEBI | CHEBI:28300 |
| ChEMBL | CHEMBL: CHEMBL93 |
| ChemSpider | 575 |
| DrugBank | DB00158 |
| ECHA InfoCard | 100990-21-6 |
| EC Number | 200-419-0 |
| Gmelin Reference | 9668 |
| KEGG | C06399 |
| MeSH | D009377 |
| PubChem CID | 6037 |
| RTECS number | GZK235S1WW |
| UNII | 9D204ZJ9Q2 |
| UN number | UN Not Listed |
| Properties | |
| Chemical formula | C19H19N7O6 |
| Molar mass | 441.4 g/mol |
| Appearance | Yellow, crystalline powder |
| Odor | Odorless |
| Density | 0.68 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | −2.5 |
| Vapor pressure | Negligible |
| Acidity (pKa) | pKa1 = 2.3, pKa2 = 4.7, pKa3 = 6.8 |
| Basicity (pKb) | pKb = 6.80 |
| Refractive index (nD) | 1.792 |
| Dipole moment | 2.4397 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 596.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | '-2084 kJ/mol' |
| Std enthalpy of combustion (ΔcH⦵298) | -2116 kJ/mol |
| Pharmacology | |
| ATC code | B03BB01 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | Keep out of reach of children; Do not store above 25°C; Protect from light; Oral use |
| Signal word | Warning |
| Hazard statements | Not a hazardous substance or mixture according to the Globally Harmonized System (GHS). |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Keep out of reach of children. |
| NFPA 704 (fire diamond) | Health: 1, Flammability: 0, Instability: 0, Special: - |
| Autoignition temperature | > 350 °C |
| Lethal dose or concentration | LD50 (oral, rat): > 10,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 10,000 mg/kg |
| NIOSH | IMF0007 |
| PEL (Permissible) | 10 mg |
| REL (Recommended) | 400 mcg |
| Related compounds | |
| Related compounds | Pteridine Pteroic acid Dihydrofolic acid Tetrahydrofolic acid Methyltetrahydrofolate Leucovorin |
| Property | Description / Manufacturer Commentary |
|---|---|
| Product Name | Folic Acid |
| IUPAC Name | (2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)amino]pentanedioic acid |
| Chemical Formula | C19H19N7O6 |
| Synonyms & Trade Names | Pteroylglutamic Acid, Vitamin B9, Folacin, Folate (synthetic) |
| HS Code & Customs Classification | 2936.26 (Vitamins and their derivatives, unmixed) National sub-codes may further differentiate grade and form based on local regulatory schedules—technical and nutritional grade are not always classified identically by customs authorities. |
Folic acid production draws heavily on the consistency of raw materials including p-aminobenzoic acid, glutamic acid, and synthetic pterins. Process selection varies according to end-use: pharmaceutical, food, or feed. Each application leverages specific purity targets, with food and pharma focusing on trace impurity control and rigorous analytical verification. Non-pharma grades may accept broader impurity profiles where performance rather than human administration dictates limits.
The material's function as a micronutrient means residual solvents and trace metals are monitored stringently for food and pharma routes. Applications in fortification, formulation, and feed supplement demand specification alignment at the point of batch release. Formulation compatibility, solubility characteristics, and reactivity profiles depend on how the grade is processed, isolated, and dried post-synthesis.
Moisture sensitivity can alter performance during blending and direct compaction for tablet or premix manufacture. Grades formulated for dry mixing behave differently from those destined for wet granulation. Storage and transportation in manufacturer-controlled environments aim to maintain lump-free powder flow and prevent caking, which is tightly linked to both humidity control in packaging areas and point-of-use location.
Quality assurance relies on both in-process and final batch analysis, with predefined acceptance bands for major and trace impurities. Typical values, such as assay range and impurity maxima, are set by internal release protocols, regulatory submissions, and direct customer negotiation. Each market may present unique regulatory benchmarks—USP, EP, JP monographs diverge in test emphasis and impurity identifications. Any deviation triggers root cause analysis and, if batch disposition cannot be justified, full disposition procedures activate per ISO/QMS requirements.
HS coding for folic acid falls under vitamins as outlined above, but import/export often encounters additional documentation or certification requests reflecting local public health priorities. Finished forms, such as encapsulated folic acid or those destined for specific food applications, can incur differing declarations or tariff treatments even under the same root heading. Groups responsible for compliance must check end-use declarations at the commercial contract stage.
Production batches of folic acid most often yield a fine yellow to orange-yellow crystalline powder with no noticeable odor. The exact shade of color may shift depending on process impurities and grade purification, especially for feed, food, or pharma applications where visual appearance impacts batch release. Melting behavior depends on grade purity; most high-purity forms begin to decompose before traditional melting is observed. Manufacturers do not normally report a boiling point due to decomposition. Bulk density and tap density are application-driven and controlled through crystallization and drying parameters to ensure flow and mixing in downstream processing.
Folic acid exhibits sensitivity to heat, humidity, light (especially ultraviolet), and oxidative environments, leading to gradual loss of assay value and emergence of degradation products. Stability in finished product form depends heavily on grade purity, particle size, as well as excipient choice and packaging. Typical plant protocols employ inert-gas blanketing or light-blocking containers for long-term storage. Solution stability degrades rapidly above neutral pH, which restricts application in aqueous products unless buffered and stabilized.
Solubility in water remains low in neutral or acidic conditions, with bulk grades relying on alkaline solution for analytical determination. Dispersibility and wetting in formulation tanks require vigorous agitation, especially in high-volume batches. Industrial users prepare solutions using freshly dissolved product, with temperature and pH control to minimize breakdown. This property influences choice of blending method and timing in final product assembly.
Each application sector—pharmaceutical, feed, food fortification—sets different quality cutoffs. Pharmaceutical grades typically demand the highest assay and the strictest impurity controls, verified by compendial testing. Feed and food grades may accept broader impurity and particle size ranges but always call for clear definition of acceptable heavy metal and solvent residue limits. Detailed parameters, such as moisture, related substances, heavy metals, and particle size, depend on the product’s intended use and customer requirements.
Main impurity sources stem from raw materials, reaction side-products, and process intermediates. Key focus goes to pteroic acid derivatives, residual solvents, and trace metals from catalysts or glassware. Impurity profile evolves with process route and grade; each plant run validates removal via purification. Released batches undergo detailed impurity mapping according to applicable pharmacopoeia or client specification, and internal trends are monitored to manage process drift over time.
Quality control applies reference methods defined by pharmacopoeias or industry bodies (such as HPLC for assay and related substances, potentiometry for moisture, atomic absorption for metals). Analytical scope and validation level change by grade; pharma-bound lots require full traceability and extended batch records. Test method selection adjusts according to client, national, and export destination standards.
Raw material selection drives both impurity profile and environmental factors. Principal feedstocks—p-aminobenzoic acid, glutamic acid, and 2,4,6-triaminopyrimidine—are sourced against purity and traceability criteria. The origin of these chemicals can affect both cost structure and impurity burden, so sourcing contracts include supply chain transparency.
The most common industrial process follows a multistep route: initial condensation of p-aminobenzoic acid with 2,4,6-triaminopyrimidine, then conjugation with glutamic acid. Catalysis, choice of solvent, pH, and temperature cycling are controlled tightly to maximize conversion and restrict formation of structurally related impurities.
Progression through reaction steps requires continuous in-process sampling for assay, side-product quantification, and endpoint determination. Purification leans on selective crystallization, solvent extraction, or chromatography to drive impurity levels within specification. Filtration, drying, and sieving define final bulk properties. Control points include verification of intermediates, solvent removal, and residual analysis to guarantee repeatability.
Batch consistency depends on rigorous in-process analytical checks and adherence to validated protocols. Each product release meets internally set or customer-agreed purity, assay, and contaminant levels. Out-of-trend observations trigger investigation and process review. Final quality documentation and batch records support regulatory audit or client review.
Folic acid undergoes reduction, hydrolysis, and conjugation reactions. Modification, such as reduction to tetrahydrofolic acid, requires well-defined catalyst and reducing agent systems, as well as oxygen-free environment. Chemical integrity degrades in strongly acidic or basic conditions, particularly at elevated temperatures.
Conversion and derivatization are temperature- and pH-sensitive. Catalysts used for reduction steps typically include platinum or palladium on carbon, and process optimization focuses on minimizing side-reactions and over-reduction. Industrial plants monitor all reactions via chromatographic endpoints, with downstream application use determining whether modification is performed in-house or by downstream customer.
Industrial folic acid serves as precursor for several downstream folate derivatives used in research or therapy. Suitability for further processing hinges on base purity and the exclusion of trace reactive materials. Applications dictate if further modification transpires at our plant, at contract partners, or in integrated customer sites with higher regulatory requirements.
Folic acid’s sensitivity to light and humidity dictates dark, airtight packaging in bulk storage rooms maintained at stable low to ambient temperatures. Excess heat and direct sunlight deteriorate potency. Critical grades (e.g., pharma) employ nitrogen-flushing or desiccant.
High-grade material is packed in food- or pharma-compliant polyethylene liners, with secondary drum or carton protection. Secondary containment reduces oxygen and light exposure. Direct contact with metals or non-inert plastics is avoided to prevent degradation or contamination.
Shelf life depends on grade, packaging, and storage; product is visually checked for color change and any evidence of caking or solution instability. Loss of potency, off-specification assay, or altered impurity profile indicate onset of degradation. Standard practice includes routine retesting for material held beyond recommended storage intervals.
Regulatory authorities generally classify folic acid with low acute toxicity for oral exposure, but direct handling on plant floor still requires personal protective equipment to control dust inhalation and prevent skin/eye contact. Up-to-date GHS hazard and precautionary statements guide site-specific PPE policies, dust extraction, and spill cleanup.
Operators manage inhalation and ingestion risks primarily by controlling airborne powder and practicing good hygiene. Eye protection and gloves remain standard in both production and QC labs. Fine powder presents some dust explosion risk, which guides plant layout and equipment selection.
Toxicological reviews cite low mammalian acute oral toxicity; chronic risk is considered negligible for occupational exposure at standard handling levels and ventilation. Exposure control focuses on respirable particulates in formulation and drying areas. Plants follow regionally mandated exposure monitoring and enforce local occupational exposure limits where defined.
Our folic acid production relies on a continuous batch synthesis process. Annual output depends on demand cycles, raw material supply stability, and reactor utilization rates. API and food-grade folic acid production run on segregated lines. Scale changes arise mostly from raw material allocation or production optimization projects. Output ramp-up is balanced against client qualification protocols and lot-to-lot reproducibility demands, particularly for regulated markets requiring multi-batch validation.
Lead time reflects the capacity status, formulation complexity, and grade. For immediate requirements, standard commercial volumes are maintained. MOQ for pharmaceutical and nutraceutical grades incorporates regulatory sampling and manufacturing batch size, not just downstream packaging minimums. Shorter lead times are possible for off-the-shelf stock, while customized presentations tie directly to process planning and line changeover scheduling.
Industrial packaging selection is driven by product grade, photostability concerns, lot traceability, and shipping route. Folic acid for synthesis and formulation is typically packed under inert gas or sealed foil, depending on exposure sensitivity. For food and premix lines, bulk containers or low particulate bags are common. Custom inner packaging and tamper-evident seals are available where GMP or HACCP protocols require additional safeguards.
Shipping configuration depends on end-market regulatory risk and transit duration. We coordinate incoterms to match client risk management policies—EXW, FOB, or CFR. Payment terms align to creditworthiness and contract frequency, with LC, TT, or supply agreement models. For new markets, payment terms reflect local business practice and account status.
Folic acid cost structure rests heavily on commodity intermediates such as p-aminobenzoylglutamic acid and various protected pteridine precursors. These upstream materials are sensitive to energy costs and supply chain interruptions from specialty chemicals. The labor share in total cost grows for pharmaceutical grades due to intensive QC and documentation steps. Process solvents and reagents account for a smaller but non-trivial share since solvent recovery rates can fluctuate seasonally.
Volatility arises primarily from swings in precursor availability, environmental compliance fees, and abrupt changes in energy tariffs. Demand-side drivers include spikes tied to fortification mandates or sudden regulatory changes, impacting planning for food, premix, and generic formulation suppliers. Disruptive events—geopolitical instability, export controls, or domestic transport bans—multiply raw material uncertainties, especially for certain regional input producers.
Price bands reflect grade, purity specification, and packaging certification status. Pharmaceutical-grade folic acid carries a premium due to enhanced analytical release, multi-stage documentation, and compliance audits. Food grades are tiered according to purity thresholds (based on client assay requirements), color tolerances, and heavy metal content. Packaging type further influences price due to validated traceability or cleanroom packing. Certification for organic, allergen-free, or GMO-free requires dedicated segregation, adding overhead not present in standard grades.
Folic acid supply and demand move in sync with regulatory fortification policies, regional dietary supplement uptake, and seasonal purchasing cycles. The major production centers are in Asia, supporting global sales, with China and India hosting the largest synthesis and downstream formulation clusters. Competition is strongest at the raw material level, while Western economies place greater premium on regulatory compliance and traceability.
US and EU demand flows from both food fortification schemes and prescription-grade applications. Regulatory hurdles slow supply ramp-up in these regions. Japan’s regulatory model directs volume to smaller lot supply, emphasizing traceability and documentation. In India and China, cost-driven volume sales dominate, with lower entry barriers but higher exposure to raw material bottlenecks. Each market’s pricing tier reflects local compliance costs and currency volatility.
Current market conditions point to moderate upward price drift through 2026, tied to input cost inflation and tighter environmental oversight on precursor synthesis. Unexpected demand surges—such as renewed fortification mandates—could trigger short-term spikes. More stringent EU and US compliance may widen the premium between food and pharmaceutical grades. Data reflects publicly disclosed supply chain indices, production investment trends, and regulatory statements from leading economies.
Market analysis draws from export/import data, producer disclosures, regulatory filings, and price indices reported by industry associations. Downstream user interviews and contract award reports supplement regional demand side figures. Price trend projections are based on moving averages of raw material costs and sector-specific compliance announcements.
Recent announcements from several Asian suppliers indicate phased investment in solvent recovery and waste reduction upgrades. These projects aim to reduce unit emissions and lower regulatory risk, though in the transition period, output may temporarily tighten. Multiple Western buyers have signaled interest in audits and longer-term supply contracts to stabilize pricing and availability, reflecting lessons from recent logistics disruptions.
EU authorities are pursuing stricter scrutiny on heavy metal content and residual solvents, impacting release requirements for batches targeting European clients. In the US, new state-level fortification schemes are under review, which could shift regional demand. India and China are enacting environmental controls on high-pollutant intermediates, influencing upstream cost structure.
Production teams prioritize backward integration for critical upstream intermediates, expanding in-house synthesis to buffer supply-side shocks. Quality and regulatory teams coordinate third-party audits and ongoing method validation to meet evolving compliance targets. Expansion of packaging automation supports improved lot traceability and inventory management for high-volume customers. Supply teams maintain rolling safety stock and diversify logistics routes to avoid single-point disruption in cross-border trade.
Folic acid produced at industrial scale serves distinct processes and regulatory landscapes. In our manufacturing lines, grades are differentiated at the earliest production stages based on end-use requirements. The three main sectors are:
| Application | Recommended Grade | Comments |
|---|---|---|
| Dietary Supplements | USP/Ph. Eur./FCC | Batch control focuses on organic impurity levels and residual solvents in line with compendial monographs. |
| Food Fortification | Food-grade | Compliance with food additive regulations, allergen risk evaluation, and particle homogeneity are central during production. |
| Pharmaceutical API | EP/USP/JP grade | Release testing is referenced to pharmacopeial identities and impurity profiling driven by regulatory filings. |
Decide if folic acid is destined for supplement, food fortification, or pharmaceutical formulation. The differences in legislative oversight and end-user health risks guide both grade selection and specification negotiation.
Review national or supranational regulations for folic acid limits, allowable excipients, and compendial references. For example, the regulatory framework for infant nutrition in China or the EU puts additional quality constraints compared to general food applications.
Supply chain traceability for pharmaceutical and supplement applications requires manufacturing lots to remain within agreed specifications for organic and inorganic impurities. Requirements can diverge sharply—select the grade with a proven release record that matches intended use (e.g., low lead or arsenic for infant formula, lower unspecified impurities for parenteral use).
Consumption volume directly affects optimal bulk packaging and transport mode. For continuous food production, bulk-pack solutions reduce handling labor, but require validated shelf life and confirmed stability for long-haul transit. Budget is also influenced by batch lot testing scope and documentation burden. Small volumes for clinical trials necessitate tighter documentation than high-volume food batches.
Before committing to a bulk purchase, obtain a lot-specific sample with a full analytical report. In-process QC and customer lab validation capture unanticipated formulation or blending issues (for example, unexpected hygroscopicity or color shade variance). Collaboration between technical teams ensures the grade matches both formulation demands and quality control expectations.
In industrial-scale folic acid production, systems for quality control shape every step from incoming raw material inspection through to batch release. Manufacturing operations undergo regular audits for ISO 9001 or equivalent standards, ensuring attention to documentation integrity, supplier qualification, corrective actions, and consistent implementation of change management protocols. Internal criteria drive continuous review of standard operating procedures and in-process monitoring at every stage—synthesis, isolation, purification, drying, and packing.
Product certifications for folic acid vary by end-user sector and market region. For food and pharmaceutical applications, GMP certification or equivalent documentation is required, reflecting consistent management of contamination risk and traceability of production events. The facility’s control over cross-contamination risk, excipient sourcing, and allergen management aligns with what regulatory authorities expect for product use in fortification, supplements, and regulated drug manufacturing. Halal, Kosher, and other certificates hinge on the approved sources of key intermediates and compliance with process validation requirements.
Comprehensive documentation supports every lot of folic acid released. Typical documentation packages cover analysis reports referencing internal or pharmacopeial assay, impurity, and heavy metal benchmarks. Certificates of Analysis are available in line with grade and end-use sector, and batch traceability extends to origin of precursors and solvents. Retained samples and historical quality records allow manufacturers to respond swiftly if a deviation or recall situation develops down the downstream supply chain.
Continuous-feed or multi-batch reactor design is selected based on ongoing demand and specific grade requirements. The production setup aims to meet planned volumes for food, feed, or pharma sectors, with operational flexibility maintained through advance raw material stockpiling and logistical forecasting. Adjustable output provides the capacity reserve necessary when surges in demand are observed or when customers move from sample stage to large-scale orders.
Core capacity is managed by integrating redundancy in upstream process units and maintaining validated cleaning, sterilization, and material-handling protocols. Monthly and annual planning considers both contractual obligations and spot orders, reducing supply volatility. Management of multiple production lines or modular setup supports differentiation in grade or documentation package while sustaining steady overall supply.
Customers with specific formulation, application, or downstream requirements can request graded samples through direct technical liaison. Sample size, documentation requirements, grade specifications, and testing method alignment are discussed directly with operations and quality staff to avoid misalignment with downstream standards or regulatory expectations. Samples are drawn from full-scale production batches, not pilot-scale or R&D runs, to provide a realistic basis for qualification exercises.
Business cooperation options reflect the dynamics of the market and differences in customer inventory models. Framework agreements or rolling-forecast supply provide assured pipeline continuity for established customers. Spot purchasing, consignment stock, and specialized call-off arrangements cater to clients facing real-time production scheduling or less predictable order flow. Supply chain resilience is built on both forward planning and continuous feedback—from customers and through on-site process monitoring. Any alteration to grade or documentation package is subject to collaborative technical review, ensuring all regulatory and end-use application requirements are reflected before order initiation.
Industrial R&D teams focus heavily on process yield improvement and impurity profile refinement. Fermentation and chemical synthesis compete as major production routes, each with distinct technical challenges for scale-up and purity assurance. Process chemists delve into byproduct minimization, optimizing reaction step efficiency, and solvent recovery. Analytical development pushes for robust impurity detection at increasingly low thresholds. Downstream, micronization and granulation technology receive significant investment as industries seek tighter control over particle size and flow properties. For end-use applications, microencapsulation and formulation stability in feed and pharma remain active research domains.
Besides established roles in nutraceuticals and food fortification, R&D groups track rising interest from medical nutrition, parenteral formulations, and functional foods that demand strict particulate and microbiological profiles. Feed manufacturers call for custom dispersibility and dusting behavior, driving collaboration between application labs and process engineers. Environmental management in synthesis, including solvent management and effluent control, grabs increasing attention where regulatory standards tighten.
Production plants grapple with batch-to-batch color, solubility variance, and trace residue management, particularly as downstream regulators and clients demand higher purity. Microbial contamination during storage and distribution, particularly in humid regions, provokes continued investment in moisture control and packaging solutions. Continuous purification technology and integrated process analytics reduce operator variability and enable quicker root-cause identification after OOS events. New ligand-based purification techniques, automatable to GMP standards, now play a key role in advanced installations.
Demand expectation rises steadily across fortified foods, pharmaceutical intermediates, and feed sectors, especially as micronutrient policies evolve in developing economies. Large-scale integration of food and pharma supply chains drives requests for traceability and real-time release testing. Regulatory tightening in North America and Europe triggers upgrades in batch record transparency, technical data provision, and environmental reporting from manufacturers.
Tomorrow’s folic acid plants increasingly prioritize closed-loop solvent recovery and reduced energy consumption per unit output. Equipment retrofits favor modular reactors and in-line analytical systems to minimize manual intervention and accelerate scale changeover. In downstream handling, sensor-based powder flow control and fully automated filling lines become more common. Technology roadmaps show upskilling in process automation, digital twin implementation, and AI-assisted deviation analysis as must-haves for maintaining global supply.
Raw material sourcing trends toward renewable glucose feedstocks and low-impact reagents, a shift visible in newer process route selections. Plant chemists weigh raw material origin, carbon intensity of utility use, and options for byproduct valorization. Implementation of solvent-free purification and solid-phase extraction aligns with increasing sustainability audits from key buyers. Producers who can demonstrate cradle-to-gate emissions control and compliance with local environmental discharge limits retain greater access to export markets.
Process engineers and application chemists respond directly to client queries on reactivity, solubility, and downstream processing issues. Troubleshooting extends from scale-up advice to impurity management in finished applications. Custom datasheets and compliance declarations—covering trace metals, allergens, microbial status, and batch-specific deviation reports—support validation and registration work for users in food, pharma, and veterinary sectors.
Formulation support addresses specific end-use constraints— tablet disintegration, feed mixing behavior, beverage compatibility, and color consistency under varying pH conditions. Application labs offer pre-launch testing and stability studies, adapting process parameters to the unique requirements of each customer’s plant and regulatory regime.
Batch-specific technical documentation accompanies every lot, with immediate response protocols for deviation support or customer complaint investigation. Quality control teams hold comprehensive sample retain libraries and maintain real-time release protocols in compliance with customer audit demands. Ongoing engagement covers documentation updates after regulatory or specification changes and helps ensure traceable correction of any non-conformities reported from the field. Continuous customer training on handling, storage, and safe disposal underpins safe and sustainable use.
Manufacturing folic acid for industrial use requires precision built over years of handling complex chemical processes. In our facility, folic acid production runs on a dedicated line designed for consistency in crystallization and purity. We control all process parameters starting from raw material sourcing, following strict protocols established through repeated pilot-to-scale-up batches. At every stage, our focus remains on consistent product attributes for end users working in foods, feed, pharma, and supplement production.
Folic acid operates as a required ingredient in vitamin premixes for baking, cereal fortification, infant formula blending, and animal feed formulation. Major food manufacturers employ folic acid to comply with national and international food fortification policies supporting folate intake. In nutritional supplement lines, our folic acid integrates into tablets, capsules, and functional beverages. Pharmaceutical formulators count on reliable input material, since human health and regulatory compliance rely on known assay, identity, and trace impurities.
Consistency in folic acid batches matters to industrial buyers. Each lot running from our reactors is sampled and tested for assay, particle size, and impurity profile. Instruments include high-performance liquid chromatography and UV spectrophotometry along with wet chemical analyses to maintain process verification. Comprehensive documentation backs every delivery, giving procurement and technical teams substantiated quality assurance. We conduct batch release under our site quality team, separating nonconforming lots from routine output. This direct oversight and traceability allows customers to plan their own manufacturing with confidence in every consignment released from our site.
We ship folic acid from our factory in packaging formats suitable for downstream operations—multi-layer bags with food-contact liners, fiber drums, and custom unit sizes for automated dosing lines. Each type is selected to guard against moisture and light, preserving folic acid stability throughout transport and storage. We maintain a trained logistics team and dedicated warehouse management, supporting stable lead times for industrial partners working on seasonal or high-volume runs. We prepare export documentation and adhere to all required packing and labeling conventions per destination country and industry use case.
Our technical teams understand manufacturing requirements from process design to trouble-shooting in vitamin premix blending or finished dosage forms. Industrial partners often need more than just product delivery—they need a supplier who understands downstream equipment and regulatory considerations. Our support covers documentation for audits, regulatory submission support, solubility guidance, and practical help resolving blending or stability questions. These discussions draw on years of direct engagement with manufacturing sites across food, pharma, and feed sectors. We engage chemical engineers and quality specialists directly with customer projects to resolve application-specific issues quickly.
Procurement and production managers select folic acid partners based on reliable supply, regulatory support, and technical backing. We maintain direct manufacturing and shipping, allowing accurate inventory planning and just-in-time delivery models for high-volume users. Distributors gain from a stable supply foundation, supported by consistent product documentation and direct access to manufacturing expertise for downstream support. Manufacturers benefit from scheduled batch production, minimizing variation and simplifying processes in high-throughput environments. Our commercial practice rests on transparency in product performance, shipment timelines, and documentation support, fostering direct business-to-business partnerships built on process understanding.
Our factory specializes in the industrial synthesis of folic acid for food fortification, nutritional, and pharmaceutical use. We control every parameter during synthesis, handling 2-amino-4-hydroxy-6-methylpteridine and p-aminobenzoic acid coupling to pure crystalline folic acid. This allows us full oversight of both chemical structure and detectable impurities throughout scaling and production runs. Every batch reflects consistent molecular identity as C19H19N7O6 and typical molecular weight of 441.40 g/mol. Our technical team runs high-resolution analytical checks on every output.
Quality benchmarks matter in our operation. For nutritional and pharmaceutical purposes, we supply folic acid that meets or surpasses most global regulatory standards. Our finished product consistently registers a folic acid assay of not less than 97.0% on the dried basis, using validated HPLC methods. We also maintain limits for individual impurities, including related pteroic acid and p-aminobenzoic acid, often below 1.0% total impurities. Loss on drying remains typically under 8.5%, with residual solvents held at trace or undetectable levels, based on validated GC and titration.
For safety and traceability, we test for heavy metals in every lot, with lead, arsenic, and mercury routinely measured at levels well below compendial thresholds. Microbial monitoring confirms our folic acid stands free from Salmonella and E. coli contamination, with total plate counts far below food/pharma acceptance.
On-site laboratories follow pharmacopoeia and food additive monographs, using ultraviolet spectrophotometry and HPLC for identity confirmation. We run IR spectral matching and melting point checks to guarantee no adulteration or deviation. Colorimetric limit tests for impurities supplement chromatographic data. Our documentation provides traceable batch data for every shipment.
Food and supplement producers require reliable, pure folic acid for direct tableting, encapsulation, or blending into fortified foods and beverages. For pharmaceutical manufacturers, demands extend to precise assay, low impurity, and consistent crystal polymorph. Our own process control and full traceability means we can supply folic acid optimized for tablets, premixes, and liquid dispersions alike, always based on customer need and regulatory environment.
In certain regions or applications, lower residual solvents and particle size adjustments play a key role. We maintain the flexibility to meet critical customer parameters for further processing or tableting smoothness, always disclosing analytical methods and batch traceability. Compliance documentation supports all product lots, and we proactively perform additional analysis if a client needs expanded validation.
Our manufacturing strategy centers on continuous process review and analytical upgrades, improving impurity removal and quantitation as technology advances. Environmental stewardship is part of our scope, with solvent recovery and waste stream minimization part of daily production oversight. By keeping the complete production cycle in our own hands, we can offer full transparency: published specifications, named lot inspection records, and real-time process adjustments based on direct customer feedback.
We can provide detailed batch specifications upon request, including confirmatory CoA and in-depth contaminant panels. As the original manufacturer, we stand behind the composition, regulatory compliance, and performance of every batch of folic acid that leaves our facility.
As the direct producer, we understand how downstream operations rely on practical logistics and steady supply—especially when it comes to something as fundamental as Folic Acid. Over the years, customers in food fortification, pharmaceuticals, premix plants, and nutritional products have shown a clear pattern: bulk pack sizes drive efficiencies and reduce handling risks. In our standard offer, folic acid ships in 25 kg fiber drums with polyethylene liners that guard against light and moisture. For very large facilities and custom blending houses, we can fill and seal super sacks at 500 kg or even 1,000 kg. Strong demand from the premix sector has pushed us to maintain a stock of these formats, minimizing wait times at critical moments in your production calendar.
Several of our longtime partners opt for palletized shipments, stacked and shrink-wrapped as multiple drums or sacks, which can be loaded quickly alongside other key micronutrients. Project-based requirements or government tenders sometimes call for slightly different sizing or exterior labeling; our site can accommodate these adjustments if the requested quantity justifies a dedicated run. In such cases, our operations supervisor gets involved early, so details don’t slip through the cracks as orders move onto the floor.
Timely delivery starts from an accurate forecast. With core raw materials all managed in-house, our own synthesis lines produce folic acid daily. For typical 25 kg drums in full-container orders—say 5 metric tons—our lead time averages 10–14 days from confirmed purchase order to finished goods on the loading dock. For larger quantities needing super sacks or specialized repacking, we generally advise buyers to look at 2–3 weeks, including full batch testing and loading. With global shipping in mind, this buffer also accounts for extra quality review before release.
Fluctuations in market demand do occur, especially in the fourth quarter as vitamin pre-mixers finalize annual contracts. During these periods, our planners work to balance ongoing regular demand with spot orders. This strategy helps keep our production schedule robust without overcommitting to unplanned surges. Having in-house laboratories speeds up batch releases; we sample and test every lot for assay, impurities, moisture, and color well before paperwork is finalized. All documentation—Certificates of Analysis, batch records, bill of lading—are prepared in parallel with production to avoid shipment delays.
Handling bulk orders for folic acid means more than loading barrels onto trucks. Our commercial and technical teams partner with major buyers on forward contracts, multi-drop shipments, and custom labeling. Clients often request extended shelf-life testing, origin declarations, and stability data to meet regulatory needs. Our approach is hands-on, leveraging over two decades of experience in the micronutrient market. By controlling the whole process, from synthesis through to final packing, we can guarantee full traceability and batch consistency—two points that customers repeatedly say tip the scaling decision our way.
Bulk procurement works best with robust flows of information. As manufacturer, we respond to changes directly, with no intermediaries slowing progress. Real-time information on raw materials, production schedule, and finished stock levels helps our customers plan inventory and production with higher confidence. For projects requiring more frequent deliveries or staggered shipping to different factories, our logistics team creates shipment sequences to match project roll-outs. Direct procurement from our factory eliminates guesswork, giving you both price stability and quality you can count on, batch after batch.
Experience on the production floor has made one thing clear—regulatory compliance shapes every step from sourcing to shipment. When it comes to folic acid for food, pharma, or nutritional use, strict conformity with laws and regulations is non-negotiable. As the direct manufacturer, we plan our quality and documentation process to support import and distribution in the world’s key markets.
Our folic acid product, intended for food fortification and supplements, complies with internationally recognized food safety standards. For markets such as the United States and the European Union, we manufacture under Good Manufacturing Practice (GMP) conditions. Consistency and traceability start with our raw material sourcing and extend through all records in the batch history.
For export shipments, we support Food Chemicals Codex (FCC) compliance, which verifies product identity, purity, and quality. In the EU, our folic acid meets European Pharmacopoeia and E 101 food additive specifications, with each batch supplied with a comprehensive Certificate of Analysis. Our compliance allows customers to register and distribute the product under local and European food regulations.
Applications in the pharmaceutical and nutritional sector place even tighter requirements on certification. Our production process supports USP and BP monograph requirements where applicable. We rely on validated equipment, rigorous cleaning protocols, and full documentation. Each lot we release leaves with traceable records tied directly to the original manufacturing run.
Markets such as the United States may require Drug Master File (DMF) registration with the FDA. We hold the technical documentation necessary for compliant import and support regulatory filings as requested by customers. For finished dose applications, our technical and regulatory teams provide assistance throughout the dossier process.
End users look beyond chemical composition—cultural and safety requirements matter. We provide Halal and Kosher certification upon request. Our production process is designed to avoid allergen contamination or cross-contact. These certifications make our product eligible for a wider range of nutritional and infant food applications.
Effective traceability stands at the core of regulatory compliance. Each folic acid batch leaving our facility is uniquely identified, with all production and quality records retained as required by the regulatory authorities. Should any compliance issue arise in the marketplace, our recall readiness system can isolate affected material within hours, not days.
We equip our customers with regulatory documentation—Certificates of Analysis, Safety Data Sheets, and manufacturing statements—so they can clear customs and registration in every market. Our team monitors changes in global regulations, so we update our implementation as needed to support customers and avoid shipment delays.
Regulatory compliance is not a one-time event, and each year brings new scrutiny and updated expectations from health authorities worldwide. Our technical and regulatory experts track developments and adjust our operations proactively. This vigilance ensures that our folic acid remains importable and distributable wherever customers need it.
We back every shipment with the certifications required for marketplace acceptance—this is more than a checkbox, it is the foundation of safe, legal, and successful supply chain operations.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales9@alchemist-chem.com, +8615651039172 or WhatsApp: +8615651039172
